Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206960
Company: AMNEAL

Products on ANDA 206960

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
NAFTIFINE HYDROCHLORIDE	NAFTIFINE HYDROCHLORIDE	2%	CREAM;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 206960

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/10/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/12/2023	SUPPL-4	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 206960

NAFTIFINE HYDROCHLORIDE

CREAM;TOPICAL; 2%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
NAFTIFINE HYDROCHLORIDE	NAFTIFINE HYDROCHLORIDE	2%	CREAM;TOPICAL	Prescription	No	AB	206960	AMNEAL
NAFTIFINE HYDROCHLORIDE	NAFTIFINE HYDROCHLORIDE	2%	CREAM;TOPICAL	Prescription	No	AB	206901	TARO
NAFTIFINE HYDROCHLORIDE	NAFTIFINE HYDROCHLORIDE	2%	CREAM;TOPICAL	Prescription	No	AB	210038	XIROMED
NAFTIN	NAFTIFINE HYDROCHLORIDE	2%	CREAM;TOPICAL	Prescription	Yes	AB	019599	SEBELA IRELAND LTD